TVARDI THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
TVARDI THERAPEUTICS, INC. (TVRD) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$1.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$2.15M, a 177.41% decline year-over-year.
- TVARDI THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $212.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- TVARDI THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $787.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $919.00K, a 83.49% decline from fiscal 2024.
- TVARDI THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $5.57M, a 69.98% increase from fiscal 2023.
- TVARDI THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $3.27M, a 42.33% decline from fiscal 2022.
- TVARDI THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $5.68M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.94M 10-Q · filed 2026-08-14 | -$1.94M derived: sum of 3 quarters · filed 2026-08-14 | -$1.15M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $212.00K 10-Q · filed 2026-05-08 | $212.00K derived: sum of 2 quarters · filed 2026-05-08 | $999.00K derived: sum of 3 quarters · filed 2026-05-08 | $3.77M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $787.00K derived: sum of 2 quarters · filed 2026-03-31 | $3.56M derived: sum of 3 quarters · filed 2026-08-14 | $919.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $787.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.56M derived: sum of 2 quarters · filed 2026-08-14 | $919.00K 10-Q · filed 2025-11-13 | $5.53M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $132.00K 10-Q · filed 2026-08-14 | $4.74M derived: sum of 3 quarters · filed 2026-08-14 | $3.12M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$2.64M 10-Q · filed 2026-05-08 | -$2.77M 10-Q · filed 2025-05-13 | $1.97M derived: sum of 2 quarters · filed 2026-05-08 | $340.00K derived: sum of 3 quarters · filed 2026-05-08 | $13.07M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.98M derived: sum of 2 quarters · filed 2026-03-31 | $15.72M derived: sum of 3 quarters · filed 2026-03-31 | $5.57M 10-K · filed 2026-03-31 | -$21.44M 10-K · filed 2025-03-11 | |||
| 2024-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $11.11M derived: sum of 2 quarters · filed 2025-11-13 | $958.00K 10-Q · filed 2025-11-13 | -$19.15M 10-Q · filed 2024-11-14 | $4.20M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $12.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.58M 10-Q · filed 2025-08-14 | -$11.10M 10-Q · filed 2024-08-14 | $5.82M derived: sum of 3 quarters · filed 2025-08-14 | $2.92M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$10.15M 10-Q · filed 2025-05-13 | -$6.91M derived: sum of 2 quarters · filed 2025-05-13 | -$9.81M derived: sum of 3 quarters · filed 2025-05-13 | -$558.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $340.00K derived: sum of 2 quarters · filed 2025-03-11 | $9.59M derived: sum of 3 quarters · filed 2025-03-11 | $3.27M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | -$2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $6.36M derived: sum of 2 quarters · filed 2024-11-14 | $37.00K 10-Q · filed 2024-11-14 | -$4.74M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-06-30 | $9.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.94M 10-Q · filed 2024-08-14 | -$1.84M derived: sum of 3 quarters · filed 2025-03-11 | $5.14M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-03-31 | -$6.32M 10-Q · filed 2024-05-13 | -$11.09M derived: sum of 2 quarters · filed 2025-03-11 | -$4.11M derived: sum of 3 quarters · filed 2025-03-11 | -$1.28M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2022-12-31 | -$4.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $2.21M derived: sum of 2 quarters · filed 2025-03-11 | $5.04M derived: sum of 3 quarters · filed 2025-03-11 | $5.68M 10-K · filed 2025-03-11 | ||||
| 2022-09-30 | $6.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $9.81M derived: sum of 2 quarters · filed 2023-11-13 | $10.46M 10-Q · filed 2023-11-13 | $12.50M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $3.47M 10-Q · filed 2023-08-07 | $5.52M derived: sum of 3 quarters · filed 2024-03-06 | $5.84M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-03-31 | $640.00K 10-Q · filed 2023-05-15 | $2.69M derived: sum of 2 quarters · filed 2024-03-06 | $3.01M derived: sum of 3 quarters · filed 2024-03-06 | $1.62M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2021-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $2.37M derived: sum of 2 quarters · filed 2024-03-06 | $981.00K derived: sum of 3 quarters · filed 2024-03-06 | -$1.02M 10-K · filed 2024-03-06 | ||||
| 2021-09-30 | $319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$1.07M derived: sum of 2 quarters · filed 2022-11-07 | -$3.07M 10-Q · filed 2022-11-07 | -$1.25M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$3.39M 10-Q · filed 2022-08-08 | -$1.56M derived: sum of 3 quarters · filed 2023-03-06 | -$459.00K derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | -$2.00M 10-Q · filed 2022-05-09 | -$177.00K derived: sum of 2 quarters · filed 2023-03-06 | $928.00K derived: sum of 3 quarters · filed 2023-03-06 | -$2.49M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $2.93M derived: sum of 2 quarters · filed 2023-03-06 | -$490.00K derived: sum of 3 quarters · filed 2023-03-06 | -$2.78M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$2.31M derived: sum of 2 quarters · filed 2021-11-08 | -$4.61M 10-Q · filed 2021-11-08 | -$5.52M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$5.71M 10-Q · filed 2021-08-09 | -$6.63M derived: sum of 3 quarters · filed 2022-03-01 | $1.19M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$2.29M 10-Q · filed 2021-05-10 | -$3.21M derived: sum of 2 quarters · filed 2022-03-01 | $4.61M derived: sum of 3 quarters · filed 2022-03-01 | $4.06M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.90M derived: sum of 2 quarters · filed 2022-03-01 | $6.36M derived: sum of 3 quarters · filed 2022-03-01 | $6.04M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $7.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $7.27M derived: sum of 2 quarters · filed 2020-11-09 | $6.96M 10-Q · filed 2020-11-09 | $6.58M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$856.00K 10-Q · filed 2020-08-10 | -$1.24M derived: sum of 3 quarters · filed 2021-02-25 | $213.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$312.00K 10-Q · filed 2020-05-11 | -$693.00K derived: sum of 2 quarters · filed 2021-02-25 | $757.00K derived: sum of 3 quarters · filed 2021-02-25 | $6.43M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.07M derived: sum of 2 quarters · filed 2021-02-25 | $6.75M derived: sum of 3 quarters · filed 2021-02-25 | $5.12M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $7.13M derived: sum of 2 quarters · filed 2019-11-05 | $5.50M 10-Q · filed 2019-11-05 | $6.73M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $5.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $4.05M 10-Q · filed 2019-08-07 | $5.28M derived: sum of 3 quarters · filed 2020-02-27 | $5.36M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$1.63M 10-Q · filed 2019-05-07 | -$397.00K derived: sum of 2 quarters · filed 2020-02-27 | -$315.00K derived: sum of 3 quarters · filed 2020-02-27 | -$5.11M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.32M derived: sum of 2 quarters · filed 2020-02-27 | -$3.48M derived: sum of 3 quarters · filed 2020-02-27 | -$3.03M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$4.71M derived: sum of 2 quarters · filed 2018-11-06 | -$4.26M 10-Q · filed 2018-11-06 | $448.00K derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-06-30 | -$4.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$4.34M 10-Q · filed 2018-08-07 | $366.00K derived: sum of 3 quarters · filed 2019-03-12 | -$694.00K derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-03-31 | $448.00K 10-Q · filed 2018-05-09 | $5.16M derived: sum of 2 quarters · filed 2019-03-12 | $4.10M derived: sum of 3 quarters · filed 2019-03-12 | $5.89M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $3.65M derived: sum of 2 quarters · filed 2019-03-12 | $5.45M derived: sum of 3 quarters · filed 2019-03-12 | $6.26M 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $736.00K derived: sum of 2 quarters · filed 2017-11-02 | $1.56M 10-Q · filed 2017-11-02 | $3.71M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.62M 10-Q · filed 2017-08-03 | $4.77M derived: sum of 3 quarters · filed 2018-03-15 | $4.73M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | $820.00K 10-Q · filed 2017-05-04 | $2.97M derived: sum of 2 quarters · filed 2018-03-15 | $2.94M derived: sum of 3 quarters · filed 2018-03-15 | $4.02M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.12M derived: sum of 2 quarters · filed 2018-03-15 | $3.20M derived: sum of 3 quarters · filed 2018-03-15 | $3.32M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $1.05M derived: sum of 2 quarters · filed 2016-11-04 | $1.17M 10-Q · filed 2016-11-04 | -$488.00K derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.20M 10-Q · filed 2016-08-04 | -$455.00K derived: sum of 3 quarters · filed 2017-03-10 | $1.12M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-03-31 | $118.00K 10-Q · filed 2016-05-05 | -$1.54M derived: sum of 2 quarters · filed 2017-03-10 | $37.00K derived: sum of 3 quarters · filed 2017-03-10 | -$121.00K derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2014-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$81.00K derived: sum of 2 quarters · filed 2017-03-10 | -$239.00K derived: sum of 3 quarters · filed 2017-03-10 | -$12.00K 10-K · filed 2017-03-10 | ||||
| 2014-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $1.42M derived: sum of 2 quarters · filed 2015-11-09 | $1.65M 10-Q · filed 2015-11-09 | $1.10M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-06-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $69.00K 10-Q · filed 2015-08-10 | -$479.00K derived: sum of 3 quarters · filed 2016-03-11 | $452.00K derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $227.00K 10-Q · filed 2015-05-12 | -$321.00K derived: sum of 2 quarters · filed 2016-03-11 | $610.00K derived: sum of 3 quarters · filed 2016-03-11 | $1.33M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | -$548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $383.00K derived: sum of 2 quarters · filed 2016-03-11 | $1.11M derived: sum of 3 quarters · filed 2016-03-11 | $722.00K 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | $931.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.66M derived: sum of 2 quarters · filed 2014-11-10 | $1.27M 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | $725.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $339.00K 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | -$386.00K 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | -$1.31M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |